Pay in 4 interest-free payments of $5.17 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Third-party testing verification This is non-negotiable
Amsterdam, The Netherlands: 2005
Event Rates : Low absolute event rates (0.1-0.8%) suggest need for larger studies and longer follow-up to confirm clinical significance of relative risk reductions
The FTO gene (rs9939609 variant) influences how your body regulates energy balance and fat storage
whole animal knockouts) to elucidate the effects of GLP1 on energy balance and glucose metabolism
Second Natures peer-reviewed study published in JMIR Formative Research (2025) compared both medications within our programme: 3 Tirzepatide (Mounjaro) cohort (209 people): 22.1% average weight loss at 12 months 95.2% achieved at least 10% weight loss 83.7% achieved at least 15% weight loss Semaglutide (Wegovy) cohort (130 people): 17.1% average weight loss at 12 months 83.1% achieved at least 10% weight loss 56.2% achieved at least 15% weight loss Both cohorts exceeded clinical trial results, suggesting that comprehensive behavioural support enhances outcomes regardless of which medication you use
US$ 25.96
US$ 24.02
US$ 25.75
US$ 29.96
US$ 26.33
US$ 24.03
US$ 22.31
US$ 29.17
US$ 21.15
